Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kai-Qi Wu"'
Autor:
Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin, Jie Zhao, Qi Jiang, Tong Guo, Min Fang, Gui-Ling Chen
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 977-988 (2024)
Abstract Introduction Interleukin-17A (IL-17A) plays a crucial role in the pathogenesis of ankylosing spondylitis (AS), although not all patients respond to traditional IL-17A antibody treatments. QX002N injection, as a new monoclonal antibody target
Externí odkaz:
https://doaj.org/article/3e8bf46cb86548f0b5d1cf5a8c05018d
Autor:
Gui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, Ying Wu, Yuan-Hui Wang, Yu-Ying Zou, Cong-Gao Peng, Jie Zhao, Chang Su, Jun-Heng Ma, Shao-Nan Ni, Xing Wang, Ting-Han Jin, Qi Jiang, Tong Guo, Yan Xu, Chao-Chao Huang, Qing Zhang, Kai-Li Liu, Li Ji, Han-Yu Yang, Chun-Lei Li, Yu-Wen Su, Xiang Lu, Lan-Juan Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTVaccination plays a key role in preventing morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to evaluate the safety and immunogenicity of a SARS-CoV-2 messenger ribonucleic acid (mRNA
Externí odkaz:
https://doaj.org/article/f56e6467fa8e4f1387547495ab11b508
Autor:
Kai-Qi Wu, Su-Fang Zhang, Chao-Hui Bao, Xin Zou, Xin Gu, Cui-Ni Wang, Wei-Ming Gong, Mei Shi, Yong-Liang Lou, Jian Huang, Ping-Yu Zhou
Publikováno v:
International Journal of Dermatology and Venerology, Vol 4, Iss 1, Pp 16-25 (2021)
Abstract. Objective:. Laboratory diagnosis of neurosyphilis (NS) remains a great challenge. This study was the aimed to identify miRNA candidates as biomarkers to distinguish between NS, non-neurosyphilis, and healthy controls (HCs). Methods:. We ana
Externí odkaz:
https://doaj.org/article/068cb037a53f4b9ca8c3982ed662e82f
Autor:
Gui-Ling Chen, MD, Xiao-Feng Li, ProfPhD, Xia-Hong Dai, PhD, Nan Li, BD, Meng-Li Cheng, MSc, Zhen Huang, MSc, Jian Shen, MD, Yu-Hua Ge, BD, Zhen-Wei Shen, PhD, Yong-Qiang Deng, PhD, Shu-Yuan Yang, MSc, Hui Zhao, PhD, Na-Na Zhang, MSc, Yi-Fei Zhang, BSc, Ling Wei, MSc, Kai-Qi Wu, MD, Meng-Fei Zhu, ProfPhD, Cong-Gao Peng, MD, Qi Jiang, BD, Shou-Chun Cao, ProfPhD, Yu-Hua Li, ProfPhD, Dan-Hua Zhao, PhD, Xiao-Hong Wu, PhD, Ling Ni, PhD, Hua-Hao Shen, PhD, Chen Dong, ProfPhD, Bo Ying, PhD, Guo-Ping Sheng, PhD, Cheng-Feng Qin, ProfPhD, Hai-Nv Gao, ProfPhD, Lan-Juan Li, ProfPhD
Publikováno v:
The Lancet Microbe, Vol 3, Iss 3, Pp e193-e202 (2022)
Summary: Background: Safe and effective vaccines are urgently needed to end the COVID-19 pandemic caused by SARS-CoV-2 infection. We aimed to assess the preliminary safety, tolerability, and immunogenicity of an mRNA vaccine ARCoV, which encodes the
Externí odkaz:
https://doaj.org/article/c132ff45bbb346039d3f564c8533d0f8